Accelerates AI Evolution: AccelStor Introduces Next Generation High Availability All-NVMe Flash Array
AccelStor, the software-defined all-flash array provider, announced a new high availability all-NVMe flash storage array, the NeoSapphire H810, accelerating the AI era with its uncompromising performance, endurance and capacity topped with AccelStor’s FlexiRemap® flash-oriented software technology. The NeoSapphire H810 will help customers to remove their system bottlenecks by offering a truly seamless user experience. AccelStor’s all-flash array products and technology will be on display at the Flash Memory Summit 2017, Booth #132, in Hall A of the Santa Clara Convention Center, in Santa Clara, California, USA, from August 8 to 10, 2017.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170802005456/en/
AccelStor will display its new high availability all-NVMe flash storage array─NeoSapphire H810 at the Flash Memory Summit 2017 (Photo: Business Wire)
“The digital transformation is happening at an incredibly rapid pace with the ascent of the connected device, big data analysis and artificial intelligent evolution. These trends are creating tremendous opportunities and also challenges for us to deliver seamless, simple, sophisticated solutions,” said Dr. Weafon Tsao, AccelStor Vice President, “We are extremely excited about the new edge of NVMe flash. Integrating AccelStor’s FlexiRemap® technology with NVMe platform means we are able to live up to the potential of our storage solution for our performance-hungry enterprise customers with extreme low latency and maximized throughput, and furthermore, to assist them explore new business opportunities.”
Dr. Weafon Tsao, will be giving a presentation at the Flash Memory Summit, presenting “NVMeoF Enterprise All-Flash Arrays Offer Top Performance” on August 9th sharing AccelStor’s vision and ambition about the latest NVMeoF flash technology.
Ultra-high Performance and Low Latency
By leveraging the latest generation of the Intel Xeon Scalable Processor, the Purley platform increases up to 1.6x workload-optimized performance versus the prior generation. The NeoSapphire H810 is an all-NVMe flash array as 4U rack mount delivering over 6 million IOPS for 4KB random access. It delivers an overall performance increase of up to 600% compared to the previous NeoSapphire P310 all-NVMe flash array, accelerating today’s modern-day workloads including artificial intelligence, deep learning, virtualization, HPC applications and digital content creation. The H810 comes with 100GbE connectivity supporting the demand from network admins for the highest data rates over a single connection.
True High Availability of NeoSapphire H810
Thanks for the FlexiRemap® technology and shared-nothing architecture, the H810 accomplishes true high availability with no single point of failure. Its symmetric active-active failover design and real-time data synchronization offers microsecond-level access latency and the essential zero downtime.
This approach, is specifically designed to provide no single point of failure and minimal service interruptions, and we believe it is the way to true high availability. To synchronize the data between 2 nodes, AccelStor adopts a special approach for data transfer. AccelStor takes the conventional RDMA (Remote Direct Memory Access) technology to the next level. To transfer the data from node A to node B, AccelStor’s patented technology will pack random 4KB I/O as a capsule. During the capsule transfer, it will efficiently reduce I/O latency and enable fast message synchronization with minimal CPU overhead.
Even under a massive random I/O workload, AccelStor’s unique high-availability extension software, combined with the backbone of the low-latency InfiniBand interlink, enables highly efficient data transfer between the two nodes. Therefore, incoming data can be synchronized in real time and safely preserved on both nodes.
Total Package for Data Service Software Features
Powered by AccelStor’s FlexiRemap® software technology, the NeoSapphire H810 delivers abundant features for data service, advanced redirect-on-write snapshot provides both data recovery and an efficient method for capacity and performance management. The H810 also packs AccelStor’s Free Clone feature, which enables copying of datastores in the vSphere environment without allocating physical capacity. Other handy tools include snapshot backup/recovery, remote replication, inline compression, FlexiDedupe, and the vSphere Web Client plug-in. Even with these rich software features, the H810 still boosts performance for computationally intensive tasks, making data more accessible for advanced analytics.
About AccelStor, Inc.
AccelStor is accelerating the paradigm shift from conventional disk arrays to modern all-flash storage. AccelStor's NeoSapphire all-flash arrays, powered by FlexiRemap® software technology, deliver sustained high IOPS for business-critical applications. With streamlined storage management, multi-protocol support, and front-access, hot-swappable solid-state drives, the NeoSapphire series promises to resolve performance bottlenecks for I/O-intensive applications like virtualization, high-performance computing, database, and media processing. For more information about AccelStor and NeoSapphire, please visit www.accelstor.com.
*AccelStor, FlexiRemap® and NeoSapphire are trademarks or registered trademarks of AccelStor, Inc. in the United States of America and/or other countries.
Clara Lee, +886-2-77467616 ext. 2561
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha